-
Hanmi Pharm and Ferring Korea agree on joint sales of nocturia treatment
12 Jan 2026 07:10 GMT
… agreement for the nocturia-enuresis treatments Minirin Tablets, Minirin Melt … Tablets (all desmopressin acetate).
Under the agreement, Hanmi Pharmaceutical will manage … tablet formulation enhances both medication convenience and bioavailability.
Recent …
-
Expanded Indications for Hem/Onc & Antibiotic Drugs
17 Nov 2025 17:25 GMT
… Medicinal Products for Human Use (CHMP) last week, expanding treatment … progression.A phase 2 trial including 50 pediatric patients … when desmopressin alone is ineffective or contraindicated. The drug should not … 1 and IGNITE 4 trials, which included adults, …
-
Desmopressin’s Role in Renal Biopsy Bleeding Outcomes
09 Nov 2025 12:04 GMT
… trials. Such investigations would help solidify the position of desmopressin … drug efficacy and procedural safety could extend to additional areas of medicine … many developments in medicine, the insights surrounding desmopressin and bleeding management …
-
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2025 Earnings Call Transcript
08 Nov 2025 13:22 GMT
… Transcript November 6, 2025
Eton Pharmaceuticals, Inc. misses on earnings … for an oral solution of desmopressin to treat central diabetes … as that trial design that you submitted to FDA that we … where somebody stops taking treatment before they reach their …
-
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
08 Jul 2025 10:50 GMT
… the U.S. Food and Drug Administration (FDA) and has been assigned … Sean Brynjelsen, CEO of Eton Pharmaceuticals. “ET-600 represents yet another … proprietary formulation of desmopressin oral solution developed for the treatment of central …
-
Safety of Recombinant von Willebrand Factor in the Treatment of von Willebrand Disease: Real-World Data from an EU Post-Authorization Safety Study
02 Oct 2025 06:38 GMT
… in adults with VWD when desmopressin treatment alone is ineffective or … in phase 3 clinical trials,7–9 there was … practice. Phase 3 clinical trial safety populations have ranged from … rVWF infusion in the medical record. Medical record data were abstracted …
-
A pediatric urologist outlines gaps and opportunities in enuresis treatment
15 Sep 2025 20:16 GMT
… www.globalcontinence.com), a biotech company dedicated to treating … on medications long term.
Those are the only treatments we … Following our upcoming clinical trial and FDA review, we expect to … often tied to constipation. Desmopressin helps a subset, but …
-
FDA news in pediatrics: July 2025
01 Aug 2025 17:08 GMT
… Pharmaceuticals’ New Drug Application for ET-600, an oral liquid formulation of desmopressin … four phase 3 trials in the ICONIC … reduce reliance on medical formula and improve … FDA approved pegcetacoplan (Empaveli; Apellis Pharmaceuticals) as the first treatment …
-
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
07 Aug 2025 20:05 GMT
… formulation of desmopressin oral solution. … Pharmaceuticals Eton is an innovative pharmaceutical company focused on developing and commercializing treatments … and commercializing drugs that are … 2,769
—
Accrued Medicaid rebates
16,226
…
-
HLB Pep targets India in exclusive peptide deal with Bioserve Biotechnologies
06 Aug 2025 05:09 GMT
… with Indian biotechnology company Bioserve Biotechnologies, setting the … of Japanese regenerative medicine company Reprocell and … In May, its desmopressin active pharmaceutical ingredient (API), used … FDA inspection next year for ganirelix, an infertility drug …